XML 17 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Income Statements - USD ($)
$ in Millions
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Revenue $ 4,007.0 $ 3,233.0 $ 2,679.0
Cost of sales (121.0) (154.0) (106.0)
Gross profit (loss) 3,886.0 3,079.0 2,573.0
Research and development (2,071.0) (1,979.0) (1,133.0)
Selling, general and administrative (984.0) (983.0) (762.0)
Disposal, restructuring and other operating expenses, net 0.0 (6.0) (7.0)
Total operating expense (3,055.0) (2,968.0) (1,902.0)
Operating income (loss) 831.0 111.0 671.0
Income (loss) from equity investments, net (237.0) (20.0) (45.0)
Interest income, net 116.0 110.0 42.0
Other non-operating income (loss), net 10.0 11.0 3.0
Income (loss) before income taxes 720.0 212.0 671.0
Income tax benefit (expense) 72.0 93.8 (146.8)
Net income (loss) $ 792.0 $ 306.0 $ 524.0
Net income (loss) per share attributable to ordinary shareholders      
Basic (in USD per share) $ 0.75 $ 0.30 $ 0.51
Diluted (in USD per share) $ 0.75 $ 0.29 $ 0.51
Weighted average ordinary shares outstanding      
Basic (in shares) 1,050,000,000 1,027,000,000 1,025,000,000
Diluted (in shares) 1,063,000,000 1,044,000,000 1,028,000,000
External Customers      
Revenue $ 3,184.0 $ 2,509.0 $ 2,025.0
Related Parties      
Revenue $ 823.0 $ 724.0 $ 654.0